Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neogen Reports Q2 Fiscal 2009 Results
Year-to-date net income for the first six months of Neogen’s 2009 fiscal year increased 22% to $7,634,000 from $6,265,000 in FY 2008, or to $0.51 per share in
Year-to-date net income for the first six months of Neogen’s 2009 fiscal year increased 22% to $7,634,000 from $6,265,000 in FY 2008, or to $0.51 per share in
Atrium has acquired Nutri-Health Supplements (NHS) for a first consideration of $23.9 million fully paid in cash at the closing of the transaction. Two additional earn-out payments have
Bill brings vital experience in wealth of operations, manufacturing and management experience for some of the most complex equipment in the semiconductor industry. His last position was vice
As per terms of the agreement, Alliance Lithomobile will be responsible for capital sales of the Sonablate when appropriate. Misonix and Alliance Lithomobile will share the ‘fee for
Ensign has purchased the facility from an out-of-state operator who acquired the property in November 2006. Barry Port, president of the Ensign subsidiary that will include Southland, noted
Michael Klein, CEO of Renal Advantage, said: “We are pleased to announce the completion of our acquisition of National Renal Alliance. We remain confident in our belief that
This agreement extends the current agreement between the companies for a two-year period and names Response Genetics as preferred provider of genetic testing services to GlaxoSmithKline (GSK) and
Prior to joining Adaltis, Ms Cheung worked at Sanofi and at Dystar China, a spin off company of BASF. Ms Cheung will replace Jacques Deforges, the company’s current
In this newly created role, Mr Bonnar is responsible for overseeing Illumina’s global manufacturing and supply chain efforts, and will report to Joel McComb, senior vice president and
Escalon Medical has acquired Immunodiagnostic Systems Holdings’s (IDS’s) hematology business for E4.2 million which is being remitted over a period of 48 months from the completion date of